Salvador Payán Pernía: Ferritin Levels and Transferrin Saturation, Reflecting Rapid Iron Accumulation and Reduced Iron Utilization
Salvador Payán Pernía, Member of the Board of Directors of the Erythropathology Group at Spanish Society of Hematology and Hemotherapy (SEHH), shared on LinkedIn about a recent article he and his co-authord, published in Blood Advances, adding:
“I’m delighted to have contributed to this European multicentre study on acquired pure red cell aplasia (PRCA), one of the rare diseases I most enjoy managing.
Acquired PRCA is an underrecognized entity, even among hematologists, as reflected by the median time from presentation to treatment of 2 months (range: 1–204 months) observed in our study.
PRCA should be promptly suspected in any patient with severe anemia and a low reticulocyte count. In our study, earlier initiation of cyclosporine A was associated with a better response.
Our study also shows that PRCA is characterized by markedly elevated erythropoietin levels (median: 908 mIU/mL; range: 29–3000 mIU/mL), likely related to reduced degradation by erythroblasts.
These findings argue against a significant role for erythropoietin analogues in the management of PRCA.
At diagnosis, most patients had elevated ferritin levels and transferrin saturation, reflecting rapid iron accumulation and reduced iron utilization.
Reticulocytes are crucial not only for diagnosis but also as an early marker of response, as highlighted in the paper –look at the reticulocytes!
Thanks to Bruno Fattizzo and Francesco Versino for their initiative, leadership, and excellent work.”
Title: Clinical Heterogeneity and Outcome of acquired PRCA: a Multicenter European Study
Authors: Francesco Versino,Marc Michel,Jennifer Vidler, Salvador Payán-Pernía,Roochi Trikha,Shreyans A Gandhi,Sukanya Gogoi,Manujasr, Wimalachandra,Omar Racchi,Maria Teresa Lupo-Stanghellini,Sabrina Giammarco,Maria Arguello Marina,Mara Memoli,Andreas Glenthøj,Gabriele Merati, Yamuna Wasanthi Wickramasinghe,Aparna Chitharanjan,Mylene Hemmer,Mariasanta Napolitano,Margarita Jimenez-Jambrina,Filippo Brioschi, Antonio Palma-Vallelano,Tomas Jose Gonzalez-Lopez,Cristina Clissa,Marta Bortolotti,Giacinto Luca Pedone,Giorgio Alberto Croci,Francesco Passamonti, Wilma Barcellini, Austin G Kulasekararaj, Bruno Fattizzo
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination
-
Jun 3, 2026, 16:04Gurpreet Kaur Sagoo: Diagnosing PNH in Aplastic Anaemia – Looking Beyond the Marrow
-
Jun 3, 2026, 16:04Jan Hartmann: An Illustrated Review Of Viscoelastic Testing Reaches 100 Citations
-
Jun 3, 2026, 16:01Andrea Losito: For Stroke Survivors, Having a Community that Understands and Triumphs Can Make a Lasting Impact
-
Jun 3, 2026, 15:54Karen Phillips: Surprisingly High Cumulative Clinical Bleeding Events In Post-Ablation AF Patients
-
Jun 3, 2026, 15:47Michael Makris: How Haemophilia Care Is Delivered in China